Trimurthi Ltd's earnings have declined by -16.7%, whereas share price has declined -3% CAGR over the past five years, indicating the company’s share price is likely overvalued. However, for specific investment actions please consult your investment advisor.
Trimurthi Ltd share price has declined -12.1% annually (CAGR) over the past ten years.
Data is not available for this company.
Trimurthi Drugs & Pharmaceuticals is an India-based company. The Company is engaged in the manufacturing, distribution, marketing and trading of pharmaceutical products. The Companyâ€™s range of products include antibiotics, anti ulcer, anti inflammatory, antitussive/expectorant, cardiovascular, anti fungal, anti retroviral drugs, syrups and protein powder. The company since 1976 is built on the philosophy of commitment to quality and responsiveness.
2012 -The Company entered
2012 -The Company entered into a Manufacturing Agreement with M/s. Bharat Parenterals Limited, Vadodara, Gujrat for exclusive manufacture of Company's 12 products for export. The Company entered into Distribution Agreement with Zyanya Global Pte Limited, Vietnam for selling the Company's Products in Vietnam.
Business areas of the company:
The company is engaged in the manufacturing, distribution, marketing and trading of pharmaceutical products.
Pharma Business, Financial Services, Investment in Shares and Trading in Shares